118 related articles for article (PubMed ID: 12803993)
21. Modulating influence on HIV/AIDS by interacting RANTES gene variants.
An P; Nelson GW; Wang L; Donfield S; Goedert JJ; Phair J; Vlahov D; Buchbinder S; Farrar WL; Modi W; O'Brien SJ; Winkler CA
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10002-7. PubMed ID: 12114533
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms in CCL5 promoter are associated with pulmonary tuberculosis in northern Spain.
Sánchez-Castañón M; Baquero IC; Sánchez-Velasco P; Fariñas MC; Ausín F; Leyva-Cobián F; Ocejo-Vinyals JG
Int J Tuberc Lung Dis; 2009 Apr; 13(4):480-5. PubMed ID: 19335954
[TBL] [Abstract][Full Text] [Related]
23. RANTES promoter gene polymorphisms and susceptibility to severe respiratory syncytial virus-induced bronchiolitis.
Amanatidou V; Sourvinos G; Apostolakis S; Neonaki P; Tsilimigaki A; Krambovitis E; Spandidos DA
Pediatr Infect Dis J; 2008 Jan; 27(1):38-42. PubMed ID: 18162936
[TBL] [Abstract][Full Text] [Related]
24. Association of Chemotactic Chemokine Ligand 5 Polymorphisms with the Risk of Developing Severe Enterovirus 71 Infection.
Li MZ; Pang LL; Bai AY; Yu SC; Gong X; Liu N; Cai K; Xie GC; Gao WJ; Jin Y; Duan ZJ
Am J Trop Med Hyg; 2015 Oct; 93(4):709-13. PubMed ID: 26304916
[TBL] [Abstract][Full Text] [Related]
25. Association between RANTES functional polymorphisms and tuberculosis in Hong Kong Chinese.
Chu SF; Tam CM; Wong HS; Kam KM; Lau YL; Chiang AK
Genes Immun; 2007 Sep; 8(6):475-9. PubMed ID: 17625600
[TBL] [Abstract][Full Text] [Related]
26. Upregulating promoter polymorphisms of RANTES relate to atopic dermatitis.
Tanaka K; Roberts MH; Yamamoto N; Sugiura H; Uehara M; Hopkin JM
Int J Immunogenet; 2006 Dec; 33(6):423-8. PubMed ID: 17117952
[TBL] [Abstract][Full Text] [Related]
27. The regulated upon activation normal T-cell expressed and secreted (RANTES) -28C/G and -403G/A polymorphisms and asthma risk: a meta-analysis.
Xie ZK; Zhao H; Huang J; Xie ZF
Mol Diagn Ther; 2014 Oct; 18(5):523-31. PubMed ID: 25004906
[TBL] [Abstract][Full Text] [Related]
28. Protective effects of IL4-589T and RANTES-28G on HIV-1 disease progression in infected Thai females.
Wichukchinda N; Nakayama EE; Rojanawiwat A; Pathipvanich P; Auwanit W; Vongsheree S; Ariyoshi K; Sawanpanyalert P; Shioda T
AIDS; 2006 Jan; 20(2):189-96. PubMed ID: 16511411
[TBL] [Abstract][Full Text] [Related]
29. RANTES gene promoter polymorphisms are associated with bronchial hyperresponsiveness in Korean children with asthma.
Sohn MH; Kim SH; Kim KW; Jee HM; Park HS; Kim KE
Lung; 2008; 186(1):37-43. PubMed ID: 17990036
[TBL] [Abstract][Full Text] [Related]
30. RANTES gene polymorphisms are not associated with rheumatoid arthritis and atopic dermatitis: a meta-analysis.
Wen D; Du X; Qiao Y; Dong JZ; Ma CS
Int Rev Immunol; 2015; 34(6):500-8. PubMed ID: 25607251
[TBL] [Abstract][Full Text] [Related]
31. Association of the RANTES gene promoter polymorphisms -28C/G and -403G/A with pneumonia in Greek children.
Doudouliaki T; Haidopoulou K; Pappa S; Sakellaropoulou A; Tsakiridis P; Emboriadou M; Hatzistilianou M
Int J Immunopathol Pharmacol; 2013; 26(3):681-90. PubMed ID: 24067464
[TBL] [Abstract][Full Text] [Related]
32. The RANTES -403G>A promoter polymorphism in Korean men: association with serum RANTES concentration and coronary artery disease.
Jang Y; Chae JS; Hyun YJ; Koh SJ; Kim JY; Ko MJ; Rim SJ; Shin HJ; Ordovas JM; Lee JH
Clin Sci (Lond); 2007 Oct; 113(8):349-56. PubMed ID: 17504241
[TBL] [Abstract][Full Text] [Related]
33. CCR2, CX3CR1, RANTES and SDF1 genetic polymorphisms influence HIV infection in a Zimbabwean pediatric population.
Mhandire K; Duri K; Kandawasvika G; Chandiwana P; Chin'ombe N; Kanyera RB; Stray-Pedersen B; Dandara C
J Infect Dev Ctries; 2014 Oct; 8(10):1313-21. PubMed ID: 25313609
[TBL] [Abstract][Full Text] [Related]
34. Association of RANTES gene polymorphisms with susceptibility to childhood asthma: A meta-analysis.
Zhang YQ; Gao XX
Medicine (Baltimore); 2020 Jul; 99(29):e20953. PubMed ID: 32702834
[TBL] [Abstract][Full Text] [Related]
35. Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C.
Wasmuth HE; Werth A; Mueller T; Berg T; Dietrich CG; Geier A; Gartung C; Lorenzen J; Matern S; Lammert F
Hepatology; 2004 Aug; 40(2):327-34. PubMed ID: 15368437
[TBL] [Abstract][Full Text] [Related]
36. RANTES: a genetic risk marker for multiple sclerosis.
Gade-Andavolu R; Comings DE; MacMurray J; Vuthoori RK; Tourtellotte WW; Nagra RM; Cone LA
Mult Scler; 2004 Oct; 10(5):536-9. PubMed ID: 15471370
[TBL] [Abstract][Full Text] [Related]
37. Lack of association between the -403G/A promoter polymorphism in the human CCL5/RANTES chemokine gene in liver transplant outcome.
Botella C; Marín L; Moya-Quiles R; Miras M; Sánchez-Bueno F; Minguela A; Bermejo J; Parrilla P; Alvarez-López R; Muro M
Transpl Int; 2006 Feb; 19(2):98-104. PubMed ID: 16441357
[TBL] [Abstract][Full Text] [Related]
38. Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients.
Hizawa N; Makita H; Nasuhara Y; Hasegawa M; Nagai K; Ito Y; Betsuyaku T; Konno S; Nishimura M;
Eur Respir J; 2008 Aug; 32(2):372-8. PubMed ID: 18385174
[TBL] [Abstract][Full Text] [Related]
39. RANTES gene single nucleotide polymorphisms and expression in patients with chronic hepatitis B virus infection.
Duan ZP; Zhao XY; Huang DZ; He LX; Chen Y; Zhao CH; Zheng BJ
Chin Med J (Engl); 2005 Jun; 118(11):909-14. PubMed ID: 15978191
[TBL] [Abstract][Full Text] [Related]
40. RANTES/CCL5 gene polymorphisms, serum concentrations, and incident type 2 diabetes: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
Herder C; Illig T; Baumert J; Müller M; Klopp N; Khuseyinova N; Meisinger C; Poschen U; Martin S; Koenig W; Thorand B
Eur J Endocrinol; 2008 May; 158(5):R1-5. PubMed ID: 18426815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
